SG Americas Securities’s Vaxart VXRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,575
Closed -$5K 3586
2025
Q2
$5K Buy
+10,575
New +$4.6K ﹤0.01% 2868
2023
Q3
Sell
-15,055
Closed -$11K 3283
2023
Q2
$11K Sell
15,055
-32,447
-68% -$30.2K ﹤0.01% 2194
2023
Q1
$36K Sell
47,502
-968
-2% -$899 ﹤0.01% 3104
2022
Q4
$47K Sell
48,470
-11,994
-20% -$17K ﹤0.01% 2853
2022
Q3
$132K Sell
60,464
-95,030
-61% -$328K ﹤0.01% 2636
2022
Q2
$544K Buy
+155,494
New +$581K 0.01% 1893
2022
Q1
Sell
-21,585
Closed -$135K 3483
2021
Q4
$135K Sell
21,585
-26,442
-55% -$181K ﹤0.01% 2890
2021
Q3
$382K Buy
+48,027
New +$395K ﹤0.01% 2737
2021
Q2
Sell
-12,346
Closed -$75K 3275
2021
Q1
$75K Sell
12,346
-3,311
-21% -$25.5K ﹤0.01% 3120
2020
Q4
$89K Buy
+15,657
New +$99.6K ﹤0.01% 3071
2020
Q3
Sell
-24,199
Closed -$214K 3508
2020
Q2
$214K Buy
+24,199
New +$69.5K ﹤0.01% 2804

Other funds holding VXRT

SG Americas Securities's VXRT Position: Q3 2025 in Review

SG Americas Securities sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 10,575 shares — an estimated $5K sold.

SG Americas Securities first reported a position in VXRT in Q2 2020 and held it in 11 quarters. The position peaked at $544K in Q2 2022. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • SG Americas Securities reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • SG Americas Securities sold 10,575 Vaxart shares in Q3 2025, an estimated $5K.
  • SG Americas Securities first reported a position in Vaxart in Q2 2020 and held it in 11 quarters.
  • SG Americas Securities's Vaxart position peaked at $544K in Q2 2022.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on SG Americas Securities's 13F filing for Q3 2025, filed 23 Oct 2025.